Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
Abstract Background The aim of this study was to evaluate and compare the performance of intensity modulated radiation therapy (IMRT) plans, planned for low-field strength magnetic resonance (MR) guided linear accelerator (linac) delivery (labelled IMRT MRL plans), and clinical conventional volumetr...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-021-01858-7 |
id |
doaj-832cf5baf23b401e8f212610f5a5636b |
---|---|
record_format |
Article |
spelling |
doaj-832cf5baf23b401e8f212610f5a5636b2021-07-25T11:15:34ZengBMCRadiation Oncology1748-717X2021-07-0116111210.1186/s13014-021-01858-7Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancerVanessa Da Silva Mendes0Lukas Nierer1Minglun Li2Stefanie Corradini3Michael Reiner4Florian Kamp5Maximilian Niyazi6Christopher Kurz7Guillaume Landry8Claus Belka9Department of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichDepartment of Radiation Oncology, University Hospital, LMU MunichAbstract Background The aim of this study was to evaluate and compare the performance of intensity modulated radiation therapy (IMRT) plans, planned for low-field strength magnetic resonance (MR) guided linear accelerator (linac) delivery (labelled IMRT MRL plans), and clinical conventional volumetric modulated arc therapy (VMAT) plans, for the treatment of prostate cancer (PCa). Both plans used the original planning target volume (PTV) margins. Additionally, the potential dosimetric benefits of MR-guidance were estimated, by creating IMRT MRL plans using smaller PTV margins. Materials and methods 20 PCa patients previously treated with conventional VMAT were considered. For each patient, two different IMRT MRL plans using the low-field MR-linac treatment planning system were created: one with original (orig.) PTV margins and the other with reduced (red.) PTV margins. Dose indices related to target coverage, as well as dose-volume histogram (DVH) parameters for the target and organs at risk (OAR) were compared. Additionally, the estimated treatment delivery times and the number of monitor units (MU) of each plan were evaluated. Results The dose distribution in the high dose region and the target volume DVH parameters (D98%, D50%, D2% and V95%) were similar for all three types of treatment plans, with deviations below 1% in most cases. Both IMRT MRL plans (orig. and red. PTV margins) showed similar homogeneity indices (HI), however worse values for the conformity index (CI) were also found when compared to VMAT. The IMRT MRL plans showed similar OAR sparing when the orig. PTV margins were used but a significantly better sparing was feasible when red. PTV margins were applied. Higher number of MU and longer predicted treatment delivery times were seen for both IMRT MRL plans. Conclusions A comparable plan quality between VMAT and IMRT MRL plans was achieved, when applying the same PTV margin. However, online MR-guided adaptive radiotherapy allows for a reduction of PTV margins. With a red. PTV margin, better sparing of the surrounding tissues can be achieved, while maintaining adequate target coverage. Nonetheless, longer treatment delivery times, characteristic for the IMRT technique, have to be expected.https://doi.org/10.1186/s13014-021-01858-7IMRTVMATIGRTMR-guidanceMRIdian linacLow-field MR-linac |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vanessa Da Silva Mendes Lukas Nierer Minglun Li Stefanie Corradini Michael Reiner Florian Kamp Maximilian Niyazi Christopher Kurz Guillaume Landry Claus Belka |
spellingShingle |
Vanessa Da Silva Mendes Lukas Nierer Minglun Li Stefanie Corradini Michael Reiner Florian Kamp Maximilian Niyazi Christopher Kurz Guillaume Landry Claus Belka Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer Radiation Oncology IMRT VMAT IGRT MR-guidance MRIdian linac Low-field MR-linac |
author_facet |
Vanessa Da Silva Mendes Lukas Nierer Minglun Li Stefanie Corradini Michael Reiner Florian Kamp Maximilian Niyazi Christopher Kurz Guillaume Landry Claus Belka |
author_sort |
Vanessa Da Silva Mendes |
title |
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer |
title_short |
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer |
title_full |
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer |
title_fullStr |
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer |
title_full_unstemmed |
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer |
title_sort |
dosimetric comparison of mr-linac-based imrt and conventional vmat treatment plans for prostate cancer |
publisher |
BMC |
series |
Radiation Oncology |
issn |
1748-717X |
publishDate |
2021-07-01 |
description |
Abstract Background The aim of this study was to evaluate and compare the performance of intensity modulated radiation therapy (IMRT) plans, planned for low-field strength magnetic resonance (MR) guided linear accelerator (linac) delivery (labelled IMRT MRL plans), and clinical conventional volumetric modulated arc therapy (VMAT) plans, for the treatment of prostate cancer (PCa). Both plans used the original planning target volume (PTV) margins. Additionally, the potential dosimetric benefits of MR-guidance were estimated, by creating IMRT MRL plans using smaller PTV margins. Materials and methods 20 PCa patients previously treated with conventional VMAT were considered. For each patient, two different IMRT MRL plans using the low-field MR-linac treatment planning system were created: one with original (orig.) PTV margins and the other with reduced (red.) PTV margins. Dose indices related to target coverage, as well as dose-volume histogram (DVH) parameters for the target and organs at risk (OAR) were compared. Additionally, the estimated treatment delivery times and the number of monitor units (MU) of each plan were evaluated. Results The dose distribution in the high dose region and the target volume DVH parameters (D98%, D50%, D2% and V95%) were similar for all three types of treatment plans, with deviations below 1% in most cases. Both IMRT MRL plans (orig. and red. PTV margins) showed similar homogeneity indices (HI), however worse values for the conformity index (CI) were also found when compared to VMAT. The IMRT MRL plans showed similar OAR sparing when the orig. PTV margins were used but a significantly better sparing was feasible when red. PTV margins were applied. Higher number of MU and longer predicted treatment delivery times were seen for both IMRT MRL plans. Conclusions A comparable plan quality between VMAT and IMRT MRL plans was achieved, when applying the same PTV margin. However, online MR-guided adaptive radiotherapy allows for a reduction of PTV margins. With a red. PTV margin, better sparing of the surrounding tissues can be achieved, while maintaining adequate target coverage. Nonetheless, longer treatment delivery times, characteristic for the IMRT technique, have to be expected. |
topic |
IMRT VMAT IGRT MR-guidance MRIdian linac Low-field MR-linac |
url |
https://doi.org/10.1186/s13014-021-01858-7 |
work_keys_str_mv |
AT vanessadasilvamendes dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT lukasnierer dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT minglunli dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT stefaniecorradini dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT michaelreiner dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT floriankamp dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT maximilianniyazi dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT christopherkurz dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT guillaumelandry dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer AT clausbelka dosimetriccomparisonofmrlinacbasedimrtandconventionalvmattreatmentplansforprostatecancer |
_version_ |
1721283313411293184 |